# Align Technology (ALGN) — News

ALGN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/algn/news

## Recent headlines

- [Align Technology, Inc.: Leerink partners cuts target price to $215 from $235](https://www.ainvest.com/news/align-technology-leerink-partners-cuts-target-price-215-235-2610) — AInvest Wire, Oct 14, 2026
  Leerink Partners has revised its target price for Align Technology, Inc. (NASDAQ: ALGN) to $215 from $235, reflecting a 8.5% reduction in the firm’s price objective for the dental technology company. The adjustment comes amid ongoing market evaluation of Align’s performance and strategic direction.…
- [Sneader: Very positive on the impact of AI on the business](https://www.ainvest.com/news/sneader-positive-impact-ai-business-2610) — AInvest Wire, Oct 14, 2026
  AI is increasingly viewed as a transformative force in business strategy, with many leaders expressing optimism about its potential to enhance productivity and decision-making. According to Sneader, the impact of AI on business is very positive, as it enables organizations to automate repetitive…
- [Align Technology, Inc.: Stifel cuts target price to $175 from $210](https://www.ainvest.com/news/align-technology-stifel-cuts-target-price-175-210-2610) — AInvest Wire, Oct 9, 2026
  Stifel has revised its target price for Align Technology, Inc. (ALGN) to $175 per share, down from a previous estimate of $210 . The adjustment reflects updated analyst assessments of the company’s financial outlook and market conditions. While the firm maintains a "Buy" rating for the stock, the…
- [Invisalign maker hit with revived antitrust claims: Blaw](https://www.ainvest.com/news/invisalign-maker-hit-revived-antitrust-claims-blaw-2610) — AInvest Wire, Oct 5, 2026
  A recent development in antitrust litigation involves Align Technology, the manufacturer of Invisalign, as revived claims challenge its market practices. The allegations, which have resurfaced in legal proceedings, center on whether the company has engaged in anticompetitive behavior by restricting…
- [Align Technology, Inc.: Evercore ISI cuts to in line from outperform; cuts target price to $155 from $220](https://www.ainvest.com/news/align-technology-evercore-isi-cuts-line-outperform-cuts-target-price-155-220-2610) — AInvest Wire, Oct 5, 2026
  Evercore ISI has revised its rating for Align Technology, Inc. (ALGN), moving from "outperform" to "in line," while simultaneously lowering its price target from $220 to $155. This adjustment reflects a reassessment of the company’s outlook amid evolving market conditions and performance trends.…

## Similar Stocks

- [MCK](https://www.lighthorse.io/tickers/mck) — McKesson Corporation Common Stock
- [HAE](https://www.lighthorse.io/tickers/hae) — Haemonetics Corporation Common Stock
- [HSIC](https://www.lighthorse.io/tickers/hsic) — Henry Schein, Inc. - Common Stock
- [QTRX](https://www.lighthorse.io/tickers/qtrx) — Quanterix Corporation - Common Stock
- [CAH](https://www.lighthorse.io/tickers/cah) — Cardinal Health, Inc. Common Stock
- [HQY](https://www.lighthorse.io/tickers/hqy) — HealthEquity, Inc. - Common Stock
- [MEDP](https://www.lighthorse.io/tickers/medp) — Medpace Holdings, Inc. - Common Stock
- [RMD](https://www.lighthorse.io/tickers/rmd) — ResMed Inc. Common Stock
- [DXCM](https://www.lighthorse.io/tickers/dxcm) — DexCom, Inc. - Common Stock
- [NVST](https://www.lighthorse.io/tickers/nvst) — Envista Holdings Corporation Common Stock

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).